Risk Stratification Using the CHA2DS2-VASc Score in Takotsubo Syndrome: Data From the Takotsubo Italian Network

被引:26
作者
Parodi, Guido [1 ,2 ]
Scudiero, Fernando [1 ]
Citro, Rodolfo [3 ]
Silverio, Angelo [3 ]
Bellandi, Benedetta [1 ]
Zito, Concetta [4 ]
Antonini-Canterin, Francesco [5 ]
Rigo, Fausto [6 ]
Zocchi, Chiara [1 ]
Bossone, Eduardo [3 ]
Salerno-Uriarte, Jorge [7 ]
Piscione, Federico [3 ]
Di Mario, Carlo [1 ]
机构
[1] Careggi Univ Hosp, Cardiovasc & Thorac Dept, Largo Brambilla 3, Florence, Italy
[2] Sassari Univ Hosp, Clin & Intervent Cardiol, Sassari, Italy
[3] Univ Hosp San Giovanni di Dio & Ruggi dAragona, Salerno, Italy
[4] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[5] S Maria Angeli Hosp, Div Cardiol, Pordenone, Italy
[6] DellAngelo Hosp, Dept Cardiol, Venice, Italy
[7] Univ Insubria, Dept Cardiol, Osped Circolo & Fond Macchi, Varese, Italy
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2017年 / 6卷 / 09期
关键词
anticoagulant; cardiovascular events; CHA(2)DS(2)-VASc score; stroke; Takotsubo; Takotsubo cardiomyopathy; Takotsubo syndrome; ATRIAL-FIBRILLATION; CHADS(2) SCORE; STROKE RISK; OUTCOMES;
D O I
10.1161/JAHA.117.006065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The CHA(2)DS(2)-VASc score predicts stroke in patients with atrial fibrillation and has been reported to have a prognostic role even in acute coronary syndrome patients. The Takotsubo syndrome is a condition that mimics acute coronary syndrome and may present several complications including stroke. We sought to assess the ability of CHA2DS2-VASc score to predict adverse events in Takotsubo syndrome patients. Methods and Results-Overall, 371 Takotsubo syndrome patients were enrolled in a prospective registry. Patients were divided into 3 groups according to the CHA2DS2-VASc score: Group A (<= 1), B (2-3), and C (>= 4). The median CHA2DS2-VASc score was 3 (interquartile range: 2-4). Overall, 9%, 42%, and 49% were included in Group A, B, and C, respectively. Follow-up length was 26 +/- 20 months. The mortality rate was 6%, 7%, and 17% in Group A, B, and C, respectively (P=0.011). The stroke rate was 3% and not different among the 3 groups. Estimated major adverse cardiac and cerebrovascular events (the composite of death, myocardial infarction, and stroke) rates in the 3 groups were 6%, 9%, and 17% in Group A, B, and C, respectively (P=0.033). The CHA2DS2-VASc score resulted as a predictor of major adverse cardiac and cerebrovascular events (odds ratio 2.1, 95% confidence interval, 1.2-3.6; P= 0.01) and all-cause mortality (odds ratio 1.5, 95% confidence interval, 1.2-1.9; P= 0.001). Conclusions-In Takotsubo syndrome, the CHA2DS2-VASc score allows prediction of cardiovascular events and mortality at longterm follow-up.
引用
收藏
页数:6
相关论文
共 14 条
[11]   Natural History of Tako-Tsubo Cardiomyopathy [J].
Parodi, Guido ;
Bellandi, Benedetta ;
Del Pace, Stefano ;
Barchielli, Alessandro ;
Zampini, Linda ;
Velluzzi, Silvia ;
Carrabba, Nazario ;
Gensini, Gian Franco ;
Antoniucci, David .
CHEST, 2011, 139 (04) :887-892
[12]   Domestic Violence May Trigger Takotsubo Reply [J].
Pelliccia, Francesco ;
Rosano, Giuseppe .
AMERICAN JOURNAL OF MEDICINE, 2015, 128 (04) :E11-E11
[13]   Role of the CHADS2 Score in Acute Coronary Syndromes Risk of Subsequent Death or Stroke in Patients With and Without Atrial Fibrillation [J].
Poci, Dritan ;
Hartford, Marianne ;
Karlsson, Thomas ;
Herlitz, Johan ;
Edvardsson, Nils ;
Caidahl, Kenneth .
CHEST, 2012, 141 (06) :1431-1440
[14]   Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy [J].
Templin, C. ;
Ghadri, J. R. ;
Diekmann, J. ;
Napp, L. C. ;
Bataiosu, D. R. ;
Jaguszewski, M. ;
Cammann, V. L. ;
Sarcon, A. ;
Geyer, V. ;
Neumann, C. A. ;
Seifert, B. ;
Hellermann, J. ;
Schwyzer, M. ;
Eisenhardt, K. ;
Jenewein, J. ;
Franke, J. ;
Katus, H. A. ;
Burgdorf, C. ;
Schunkert, H. ;
Moeller, C. ;
Thiele, H. ;
Bauersachs, J. ;
Tschoepe, C. ;
Schultheiss, H-P. ;
Laney, C. A. ;
Rajan, L. ;
Michels, G. ;
Pfister, R. ;
Ukena, C. ;
Boehm, M. ;
Erbel, R. ;
Cuneo, A. ;
Kuck, K-H. ;
Jacobshagen, C. ;
Hasenfuss, G. ;
Karakas, M. ;
Koenig, W. ;
Rottbauer, W. ;
Said, S. M. ;
Braun-Dullaeus, R. C. ;
Cuculi, F. ;
Banning, A. ;
Fischer, T. A. ;
Vasankari, T. ;
Airaksinen, K. E. J. ;
Fijalkowski, M. ;
Rynkiewicz, A. ;
Pawlak, M. ;
Opolski, G. ;
Dworakowski, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (10) :929-938